RAPT Therapeutics, Inc. (RAPT)
NASDAQ: RAPT · Real-Time Price · USD
28.85
+1.06 (3.81%)
Nov 14, 2025, 4:00 PM EST - Market closed

RAPT Therapeutics Stock Forecast

Stock Price Forecast

The 9 analysts that cover RAPT Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $57, which forecasts a 97.57% increase in the stock price over the next year. The lowest target is $9.00 and the highest is $80.

Price Target: $57 (+97.57%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$9.00$57$60$80
Change-68.80%+97.57%+107.97%+177.30%

Analyst Ratings

The average analyst rating for RAPT Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingJun '25Jul '25Aug '25Sep '25Oct '25Nov '25
Strong Buy222344
Buy111244
Hold122211
Sell100000
Strong Sell000000
Total555799

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
JP Morgan
JP Morgan
Buy
Maintains
$55$57
BuyMaintains$55$57+97.57%Nov 12, 2025
Barclays
Barclays
Buy
Maintains
$58$56
BuyMaintains$58$56+94.11%Nov 7, 2025
Wells Fargo
Wells Fargo
Buy
Maintains
$48$72
BuyMaintains$48$72+149.57%Nov 3, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$27$72
Strong BuyMaintains$27$72+149.57%Oct 27, 2025
Guggenheim
Guggenheim
Strong Buy
Initiates
$70
Strong BuyInitiates$70+142.63%Oct 27, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-3.06
from -25.49
EPS Next Year
-3.78
from -3.06
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
5.04M3.81M1.53M----
Revenue Growth
--24.38%-59.95%----
EPS
-17.53-20.21-20.61-24.37-25.49-3.06-3.78
EPS Growth
-------
Forward PE
-------
No. Analysts
-----1010
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
Highn/an/a
Avgn/an/a
Lown/an/a

Revenue Growth

Revenue Growth20252026202720282029
High--
Avg--
Low--

EPS Forecast

EPS20252026202720282029
High-1.01-1.68
Avg-3.06-3.78
Low-5.19-6.31

EPS Growth

EPS Growth20252026202720282029
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.